Showing posts with label biologics. Show all posts
Showing posts with label biologics. Show all posts
Monday, 22 August 2022

Bipartisan Letter from U.S. Senators on Drug Patent Thickets

›
I n June, U.S. Senators Leahy (Democrat) and Cornyn (Republican) (and others) sent a letter to the United States Patent and Trademark Office...
Wednesday, 3 August 2022

Senator Tillis' New Proposed Patent Eligible Subject Matter Legislation

›
Senator Thom Tillis has been busy.  He has proposed a new act to clarify patent eligibility doctrine in the United States.  This is definite...
Wednesday, 3 November 2021

U.S. FDA Sends Letter to Push USPTO Concerning Drug Patents and Access

›
The U.S. Federal Food and Drug Administration (FDA) recently sent a letter to the U.S. Patent and Trademark Office concerning the FDA’s conc...
Friday, 6 March 2020

Another Government Report Tackling Pharmaceutical Pricing in the United States that Takes Aim at Patenting Practices

›
The State of Minnesota has recently released a 94 page report on drug pricing and access titled, “ Report of Minnesota Attorney General’s...
Thursday, 21 February 2019

Heavily Taxing Billionaires to Promote Innovation

›
An important issue confronting the world concerns the high concentration of wealth and redistribution of that wealth through the tax syste...
Sunday, 23 December 2018

Hatch-Waxman Integrity Act is Introduced in U.S. House of Representatives

›
U.S. Representative Tom Flores has introduced the Hatch Waxman Integrity Act in the House of Representatives.   The Act has also been in...
Saturday, 4 August 2018

Bloomberg Tracking Pharmaceutical Prices

›
One way the Trump Administration appears to attempt to control drug prices is through use of the “bully pulpit.”   Wikipedia states that...
Friday, 20 July 2018

New Trump Administration U.S. FDA Working Group on Importation of Pharmaceuticals

›
The U.S. Secretary of the Department of Health and Human Services, Alex Azar, has recently directed the Food and Drug Administration (FDA) C...
Thursday, 21 June 2018

Disincentivizing the Use of IPRs and PGRs Against Pharmaceutical and Biologic Patents

›
Senator Orrin Hatch has introduced legislation designed to curb the use of IPRs and PGRs against pharmaceutical and biologic patents by es...
Saturday, 12 December 2015

The Coming Increased Transparency in Pharmaceutical Pricing in the United States?

›
Pharmaceutical pricing has been viewed as a black box type of affair.   However, a recent Wall Street Journal article authored by Jonathan D...
Friday, 9 October 2015

Trans-Pacific Partnership Agreement Leaked by WikiLeaks

›
The apparent final version of the Trans-Pacific Partnership Agreement (TPP) has been leaked by WikiLeaks.   A copy can be found, here .  Whi...
Wednesday, 29 April 2015

Biotechnology Stock Value Swings

›
In a July 6, 2013 post , this blog discussed the upswing in biotechnology patenting and the rising numbers of biotechnology IPOs.   The blog...
Sunday, 13 October 2013

California Governor Jerry Brown Vetoes California’s Biosimilars Bill

›
I recently wrote about California’s Biosimilars Bill which was passed by the California Legislation.   California Governor Jerry Brown v...
1 comment: